New hope for patients with breast cancer

New drug for breast cancer prolongs life of women with metastasis cancer.

 

New breast cancer vaccine is called hTERE.
 

The vaccine is based on the protein called hTERT. It is a peptide effective in almost all the forms of cancer. Researchers claim that oligomers with the peptide link can identify the cells of the immune system and make the defence reaction stronger.

 
Test results
The vaccine was tested on 19 female volunteers, of whom 13 increased the production of T-cells. The cells reacted with hTERT protein and started attacking the cells of the tumour

The number of cancer patients is growing rapidly. 

 
Women who reacted positively to the vaccine lived, on average, 32 month longer from the commencement of therapy, while women who did not react to the therapy lived, on average, 17 months. 

The emphasis is placed on preventive, which has already been mentioned a lot of times, because it is the only thing that helps you avoid all the more frequent diseases of the modern time. Source: IntimateMedicine.com